CAS: 2279068-37-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Polatuzumab REF: TM-T77477CAS: 2279068-37-8 | SDS-PAGE:96.4%;SEC-HPLC:99.7% | 182.00 €~1,830.00 € | Thu 24 Oct 24 |
 | Polatuzumab REF: 3D-CLA1325CAS: 2279068-37-8 | - - - | To inquire | Tue 05 Nov 24 |
Polatuzumab
CAS:2279068-37-8
Polatuzumab: a monoclonal antibody targeting CD79b, delivers chemo agents, used in synthesizing Polatuzumab Vedotin.
Purity:
SDS-PAGE:96.4%;SEC-HPLC:99.7%
Color and Shape:
Solid
Molecular weight:
Approximately 145.24 kDa
Ref: TM-T77477
| 1mg | 182.00 € | ||
| 5mg | 449.00 € | ||
| 10mg | 645.00 € | ||
| 25mg | 1,007.00 € | ||
| 50mg | 1,361.00 € | ||
| 100mg | 1,830.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Ref: 3D-CLA1325
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 5 Nov 2024
